Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 110 participants.

Also called NCT07308184

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 110 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07308184
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07308184. Randomized; quadruple masking; primary purpose treatment. Start 2025-12 (anticipated); primary completion 2027-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone
Condition
Diabetes (DM)
Condition
Diabetes Mellitus Type 2
Intervention (Drug)
IN-B00009
Intervention (Drug)
Placebo
Lead sponsor
HK inno.N Corporation (class: industry)

Record details

Record id
cardio:ct-nct07308184
Content hash
2241224c056de7686637dfe878f7dc88c9b1c6b54583f2436b5811d59729a8c7